{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:36:22Z","timestamp":1771580182820,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1177\/1933719114557895","type":"journal-article","created":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T02:50:05Z","timestamp":1418179805000},"page":"743-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prediction of Fetal Growth Restriction by Analyzing the Messenger RNAs of Angiogenic Factor in the Plasma of Pregnant Women"],"prefix":"10.1007","volume":"22","author":[{"given":"Shin","family":"Takenaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Freni","family":"Sterrantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Koide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Farina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Sekizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,30]]},"reference":[{"key":"22060743_CR1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1196\/annals.1365.012","volume":"1092","author":"G Valsamakis","year":"2006","unstructured":"Valsamakis G, Kanaka-Gantenbein C, Malamitsi-Puchner A, Mastorakos G. Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome. Ann N Y Acad Sci. 2006;1092:138\u2013147.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"22060743_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1053\/j.semperi.2007.11.002","volume":"32","author":"MG Neerhof","year":"2008","unstructured":"Neerhof MG, Thaete LG. The fetal response to chronic placental insufficiency. Semin Perinatol. 2008;32(3):201\u2013205.","journal-title":"Semin Perinatol"},{"issue":"5","key":"22060743_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649\u2013658.","journal-title":"J Clin Invest"},{"issue":"1","key":"22060743_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mvr.2007.04.009","volume":"75","author":"WP Mutter","year":"2008","unstructured":"Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res. 2008;75(1):1\u20138.","journal-title":"Microvasc Res"},{"issue":"1","key":"22060743_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ajog.2006.01.014","volume":"195","author":"F Crispi","year":"2006","unstructured":"Crispi F, Dom\u00ednguez C, Llurba E, Mart\u00edn-Gall\u00e1n P, Cabero L, Gratac\u00f3s E. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol. 2006;195(1):201\u2013207.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"22060743_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1042\/CS20060161","volume":"112","author":"W Wallner","year":"2007","unstructured":"Wallner W, Sengenberger R, Strick R, et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond). 2007;112(1): 51\u201357.","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"22060743_CR7","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.ajog.2006.03.065","volume":"195","author":"MD Savvidou","year":"2006","unstructured":"Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH. Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. Am J Obstet Gynecol. 2006;195(6):1668\u20131673.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"22060743_CR8","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1210\/jc.2006-2774","volume":"92","author":"H Stepan","year":"2007","unstructured":"Stepan H, Kr\u00e4mer T, Faber R. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab. 2007;92(7):2831\u20132834.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"22060743_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1210\/jc.2007-1042","volume":"93","author":"O Nevo","year":"2008","unstructured":"Nevo O, Many A, Xu J, et al. Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab. 2008;93(1):285\u2013292.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"22060743_CR10","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1097\/01.AOG.0000265804.09161.0d","volume":"109","author":"GC Smith","year":"2007","unstructured":"Smith GC, Crossley JA, Aitken DA, et al. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Obstet Gynecol. 2007;109(6):1316\u20131324.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"22060743_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/aje\/kwq373","volume":"173","author":"BO \u00c5svold","year":"2011","unstructured":"\u00c5svold BO, Vatten LJ, Romundstad PR, Jenum PA, Karumanchi SA, Eskild A. Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction. Am J Epidemiol. 2011; 173(6):630\u2013639.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"22060743_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1210\/jc.2005-1076","volume":"91","author":"KA Wath\u00e9n","year":"2006","unstructured":"Wath\u00e9n KA, Tuutti E, Stenman UH, et al. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J Clin Endocrinol Metab. 2006;91(1):180\u2013184.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"22060743_CR13","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1210\/jc.2004-1955","volume":"90","author":"E Shibata","year":"2005","unstructured":"Shibata E, Rajakumar A, Powers RW, et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab. 2005;90(8):4895\u20134903.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"22060743_CR14","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/clinchem\/46.11.1832","volume":"46","author":"LL Poon","year":"2000","unstructured":"Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem. 2000;46(11):1832\u20131834.","journal-title":"Clin Chem"},{"issue":"8","key":"22060743_CR15","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.1073\/pnas.0637450100","volume":"100","author":"EK Ng","year":"2003","unstructured":"Ng EK, Tsui NB, Lau TK, et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA. 2003; 100(8):4748\u20134753.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"22060743_CR16","doi-asserted-by":"publisher","first-page":"e381","DOI":"10.1016\/j.ajog.2008.11.035","volume":"200","author":"Y Purwosunu","year":"2009","unstructured":"Purwosunu Y, Sekizawa A, Okazaki S, et al. Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma. Am J Obstet Gynecol. 2009;200(4):386.e381\u2013387.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"22060743_CR17","doi-asserted-by":"publisher","first-page":"e571","DOI":"10.1016\/j.ajog.2010.07.043","volume":"203","author":"A Farina","year":"2010","unstructured":"Farina A, Zucchini C, Sekizawa A, et al. Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10\u201314 weeks. Am J Obstet Gynecol. 2010; 203(6):575.e571\u2013e577.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"22060743_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1471-0528.2010.02491.x","volume":"117","author":"A Sekizawa","year":"2010","unstructured":"Sekizawa A, Purwosunu Y, Farina A, et al. Prediction of preeclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15\u201320 weeks of gestation. BJOG. 2010;117(5):557\u2013564.","journal-title":"BJOG"},{"issue":"5","key":"22060743_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/pd.2230","volume":"29","author":"WW Pang","year":"2009","unstructured":"Pang WW, Tsui MH, Sahota D, et al. A strategy for identifying circulating placental RNA markers for fetal growth assessment. Prenat Diagn. 2009;29(5):495\u2013504.","journal-title":"Prenat Diagn"},{"issue":"2","key":"22060743_CR20","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1016\/j.ajog.2013.04.011","volume":"209","author":"CL Whitehead","year":"2013","unstructured":"Whitehead CL, Walker SP, Mendis S, Lappas M, Tong S. Quantifying mRNA coding growth genes in the maternal circulation to detect fetal growth restriction. Am J Obstet Gynecol. 2013;209(2): 133. e131\u2013e139.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"22060743_CR21","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1136\/jmg.2005.040634","volume":"43","author":"S Okazaki","year":"2006","unstructured":"Okazaki S, Sekizawa A, Purwosunu Y, Iwasaki M, Farina A, Okai T. Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal blood. J Med Genet. 2006;43(9):e47.","journal-title":"J Med Genet"},{"issue":"7","key":"22060743_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7): 672\u2013683.","journal-title":"N Engl J Med"},{"issue":"2","key":"22060743_CR23","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1210\/jc.2003-031244","volume":"89","author":"R Thadhani","year":"2004","unstructured":"Thadhani R, Mutter WP, Wolf M, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab. 2004;89(2): 770\u2013775.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"22060743_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"R Romero","year":"2008","unstructured":"Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21(1):9\u201323.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"22060743_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/14767050802034545","volume":"21","author":"O Erez","year":"2008","unstructured":"Erez O, Romero R, Espinoza J, et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med. 2008; 21(5):279\u2013287.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"22060743_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/uog.3881","volume":"29","author":"A Pilalis","year":"2007","unstructured":"Pilalis A, Souka AP, Antsaklis P, et al. Screening for preeclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11\u201314 weeks\u2019 gestation. Ultrasound Obstet Gynecol. 2007;29(2): 135\u2013140.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"22060743_CR27","first-page":"378","volume":"83","author":"RA North","year":"1994","unstructured":"North RA, Ferrier C, Long D, Townend K, Kincaid-Smith P. Uterine artery Doppler flow velocity waveforms in the second trimester for the prediction of preeclampsia and fetal growth retardation. Obstet Gynecol. 1994;83(3):378\u2013386.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"22060743_CR28","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/j.1447-0756.2012.01855.x","volume":"38","author":"N Wibowo","year":"2012","unstructured":"Wibowo N, Purwosunu Y, Sekizawa A, Farina A, Idriansyah L, Fitriana I. Antioxidant supplementation in pregnant women with low antioxidant status. J Obstet Gynaecol Res. 2012;38(9): 1152\u20131161.","journal-title":"J Obstet Gynaecol Res"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719114557895.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719114557895","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719114557895\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719114557895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719114557895.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:34:01Z","timestamp":1656812041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719114557895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["22060743"],"URL":"https:\/\/doi.org\/10.1177\/1933719114557895","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"30 December 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}